Gene · 10313
NIH grants668
NIH grants whose papers are about the gene, through NIH's grant-paper links.
321 to 340 of 668
Download this page as JSON| Grant | Title | RTN3 papers | Newest fiscal year |
|---|---|---|---|
| R01DK104363 | DHA Reverses Gene Network Signatures of Fructose-induced Metabolic Syndrome | 1 | 2019 |
| R01EB021857 | Rapid 3D bioprinting of biomimetic vascularized tissue constructs | 1 | 2019 |
| R01ES024915 | Role of de novo DNMTs in Toxicant Induced Alterations in DNA Methylation | 1 | 2019 |
| R01GM057549 | Agonist Activated Phosphoinositide Kinase Scaffolds Control Motility and Survival Signals | 1 | 2019 |
| R01GM075061 | Endoplasmic Reticulum Associated Degradation (ERAD) of Membrane Proteins in Yeast | 1 | 2019 |
| R01GM099705 | TERT Promoter Mutations and Telomerase Reactivation in Cancer Cells | 1 | 2019 |
| R01GM113028 | Integration of Xenopus extract and microfluidics to study organelle size scaling | 1 | 2019 |
| R01GM114401 | Structure-function analysis of Torsin ATPases in the context of the membrane | 1 | 2019 |
| R01GM117466 | Autophagy Regulation by Hippo Kinases STK3/STK4 | 1 | 2019 |
| R01GM118486 | Enabling Nanoscale Dynamic Imaging of Vesicles and Organelles | 1 | 2019 |
| R01HL128350 | Genetic Modulation of Hypertrophic Cardiomyopathy Severity | 1 | 2019 |
| R01NS063973 | Autophagy and Neurodegeneration | 1 | 2019 |
| R01NS092343 | SIMPLE-regulated trafficking and peripheral neuropathy | 1 | 2019 |
| R01NS095654 | Heterogeneity of Forebrain Neural Precursors | 1 | 2019 |
| R03MH115426 | Transcriptional signature profiling of IGF1-treated neural cells from idiopathic autistic patients | 1 | 2019 |
| R21AA026017 | How Non-transcriptional IRF3 Prevents ALD | 1 | 2019 |
| R21ES028957 | Endocrine Disruptors, Ahr Signaling, and Placentation | 1 | 2019 |
| R21EY030716 | Highly specific control of neurons with photoswitchable bioluminescent optogenetics. | 1 | 2019 |
| R37NS083524 | Systematic discovery and functional analysis of the PARKIN modified proteome | 1 | 2019 |
| RF1AG045781 | Retromer deficiency and Alzheimer's disease pathology | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10313/grants?page=17